The following trial balance relates to Faith at 30 September 2008:
	GHS’000	GHS’000
Leasehold property – at valuation 1 October 2007 (note (i))	50,000
Plant and equipment – at cost (note (i))	76,600
Plant and equipment – accumulated depreciation at 1 October 2007		24,600
Capitalized development expenditure – at 1 October 2007 (note (ii)) 20,000
Development expenditure – accumulated amortization at 1/10/07		6,000
Closing inventory at 30 September 2008	20,000
Trade receivables	43,100
Bank		1,300
Trade payables and provisions (note (iii))		23,800
Revenue (note (i))		300,000
Cost of sales	204,000
Distribution costs	14,500
Administrative expenses (note (iii))	22,200
Preference dividend paid	800
Interest on bank borrowings	200
Equity dividend paid	6,000
Research and development costs (note (ii))	8,600
Equity shares of 25 cents each		50,000
8% redeemable preference shares of GHS1 each (note (iv))		20,000
Retained earnings at 1 October 2007		24,500
Deferred tax (note (v))		5,800
Leasehold property revaluation reserve		10,000
	––––––––	––––––––
	466,000	466,000
	––––––––	––––––––
The following notes are relevant:

1. Non-current assets – tangible:

The leasehold property had a remaining life of 20 years at 1 October 2007. The company’s policy is to revalue its property at each year end and at 30 September 2008 it was valued at GHS43 million. Ignore deferred tax on the revaluation.

On 1 October 2007 an item of plant was disposed of for GHS2·5 million cash. The proceeds have been treated as sales revenue by Faith. The plant is still included in the above trial balance figures at its cost of GHS8 million and accumulated depreciation of GHS4 million (to the date of disposal).

All plant is depreciated at 20% per annum using the reducing balance method.

Depreciation and amortization of all non-current assets is charged to cost of sales.

2. Non-current assets – intangible:

   In addition to the capitalized development expenditure (of GHS20 million), further research and development costs were incurred on a new project which commenced on 1 October 2007. The research stage of the new project lasted until 31 December 2007 and incurred GHS1·4 million of costs. From that date the project incurred development costs of GHS800,000 per month. On 1 April 2008 the directors became confident that the project would be successful and yield a profit well in excess of its costs. The project is still in development at 30 September 2008.

   Capitalized development expenditure is amortized at 20% per annum using the straight-line method. All expensed research and development is charged to cost of sales.

3. Faith is being sued by a customer for GHS2 million for breach of contract over a cancelled order. Faith has obtained legal opinion that there is a 20% chance that Faith will lose the case. Accordingly Faith has provided GHS400,000 (GHS2 million x 20%) included in administrative expenses in respect of the claim. The unrecoverable legal costs of defending the action are estimated at GHS100,000. These have not been provided for as the legal action will not go to court until next year.

4. The preference shares were issued on 1 April 2008 at par. They are redeemable at a large premium which gives them an effective finance cost of 12% per annum.

5. The directors have estimated the provision for income tax for the year ended 30 September 2008 at GHS11.4 million. The required deferred tax provision at 30 September 2008 is GHS6 million.

6. Required:

   Prepare the statement of comprehensive income for the year ended 30 September 2008.

7. Prepare the statement of changes in equity for the year ended 30 September 2008.

8. Prepare the statement of financial position as at 30 September 2008.

9. Note: notes to the financial statements are not required